Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemodynamics | 9 | 2017 | 236 | 2.470 |
Why?
|
| Fluid Therapy | 7 | 2017 | 53 | 2.340 |
Why?
|
| Critical Illness | 10 | 2019 | 341 | 2.130 |
Why?
|
| Obesity, Morbid | 4 | 2017 | 96 | 1.630 |
Why?
|
| Catheterization, Central Venous | 5 | 2022 | 88 | 1.540 |
Why?
|
| Body Surface Area | 3 | 2013 | 13 | 1.270 |
Why?
|
| Critical Care | 12 | 2019 | 417 | 1.110 |
Why?
|
| Hospital Mortality | 3 | 2019 | 856 | 1.090 |
Why?
|
| Cardiac Output | 6 | 2013 | 34 | 1.060 |
Why?
|
| Intensive Care Units | 8 | 2019 | 454 | 1.050 |
Why?
|
| Heart Arrest | 2 | 2018 | 161 | 1.030 |
Why?
|
| Water-Electrolyte Balance | 2 | 2017 | 19 | 1.000 |
Why?
|
| Respiration, Artificial | 4 | 2012 | 295 | 0.900 |
Why?
|
| Central Venous Catheters | 1 | 2022 | 17 | 0.780 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2022 | 37 | 0.760 |
Why?
|
| Body Mass Index | 2 | 2017 | 892 | 0.730 |
Why?
|
| Home Care Services | 1 | 2022 | 102 | 0.720 |
Why?
|
| Stroke Volume | 5 | 2013 | 323 | 0.660 |
Why?
|
| Pressure Ulcer | 1 | 2019 | 37 | 0.640 |
Why?
|
| Embolism, Paradoxical | 1 | 2019 | 14 | 0.640 |
Why?
|
| Anesthesiologists | 1 | 2018 | 18 | 0.610 |
Why?
|
| Advance Directives | 1 | 2018 | 46 | 0.600 |
Why?
|
| Terminal Care | 2 | 2018 | 98 | 0.590 |
Why?
|
| Humans | 43 | 2022 | 60079 | 0.590 |
Why?
|
| Edema | 1 | 2017 | 41 | 0.580 |
Why?
|
| Patient Admission | 1 | 2019 | 184 | 0.570 |
Why?
|
| Monitoring, Physiologic | 3 | 2009 | 150 | 0.570 |
Why?
|
| Postoperative Care | 1 | 2018 | 114 | 0.560 |
Why?
|
| Sepsis | 3 | 2017 | 282 | 0.560 |
Why?
|
| Thinness | 1 | 2017 | 41 | 0.550 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 302 | 0.550 |
Why?
|
| Noninvasive Ventilation | 1 | 2018 | 70 | 0.540 |
Why?
|
| Pulmonary Embolism | 1 | 2019 | 171 | 0.540 |
Why?
|
| Clostridium Infections | 1 | 2017 | 47 | 0.530 |
Why?
|
| Length of Stay | 2 | 2019 | 782 | 0.530 |
Why?
|
| Health Care Costs | 1 | 2018 | 210 | 0.530 |
Why?
|
| Shock, Septic | 2 | 2017 | 90 | 0.520 |
Why?
|
| Patient Participation | 1 | 2018 | 214 | 0.520 |
Why?
|
| Shock | 1 | 2015 | 31 | 0.510 |
Why?
|
| Chronic Disease | 1 | 2018 | 744 | 0.480 |
Why?
|
| Anticoagulants | 1 | 2019 | 489 | 0.470 |
Why?
|
| Ultrasonography, Interventional | 4 | 2022 | 92 | 0.450 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2018 | 253 | 0.450 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 2013 | 2 | 0.430 |
Why?
|
| Plasma Substitutes | 1 | 2013 | 6 | 0.430 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2013 | 15 | 0.430 |
Why?
|
| Jugular Veins | 3 | 2011 | 30 | 0.420 |
Why?
|
| Acute Kidney Injury | 2 | 2012 | 132 | 0.420 |
Why?
|
| Perioperative Care | 1 | 2013 | 79 | 0.410 |
Why?
|
| Echocardiography | 1 | 2015 | 460 | 0.410 |
Why?
|
| Erythrocyte Transfusion | 1 | 2013 | 76 | 0.410 |
Why?
|
| Blood Volume | 1 | 2012 | 42 | 0.400 |
Why?
|
| Transducers, Pressure | 1 | 2012 | 1 | 0.400 |
Why?
|
| Ephedrine | 1 | 2012 | 3 | 0.400 |
Why?
|
| Brain Death | 2 | 2016 | 18 | 0.400 |
Why?
|
| Phenylephrine | 1 | 2012 | 15 | 0.400 |
Why?
|
| Erythrocytes | 1 | 2013 | 154 | 0.400 |
Why?
|
| Quality of Life | 1 | 2019 | 1140 | 0.400 |
Why?
|
| Monitoring, Intraoperative | 1 | 2012 | 46 | 0.390 |
Why?
|
| Cardiotonic Agents | 1 | 2012 | 48 | 0.390 |
Why?
|
| Blood Pressure | 2 | 2012 | 522 | 0.390 |
Why?
|
| Catheterization, Swan-Ganz | 3 | 2007 | 14 | 0.380 |
Why?
|
| Vasoconstrictor Agents | 1 | 2012 | 64 | 0.380 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2012 | 95 | 0.380 |
Why?
|
| Echocardiography, Doppler | 1 | 2012 | 131 | 0.370 |
Why?
|
| Renal Dialysis | 1 | 2012 | 186 | 0.370 |
Why?
|
| Adult | 15 | 2019 | 15971 | 0.360 |
Why?
|
| Brain Injuries | 1 | 2011 | 137 | 0.320 |
Why?
|
| Male | 16 | 2019 | 27950 | 0.300 |
Why?
|
| Neuromuscular Blocking Agents | 3 | 2017 | 13 | 0.290 |
Why?
|
| Models, Biological | 1 | 2012 | 1142 | 0.280 |
Why?
|
| Female | 15 | 2019 | 31225 | 0.260 |
Why?
|
| Pulmonary Artery | 1 | 2006 | 90 | 0.260 |
Why?
|
| Catheters, Indwelling | 2 | 2022 | 69 | 0.250 |
Why?
|
| Protein C | 1 | 2005 | 30 | 0.250 |
Why?
|
| Logistic Models | 4 | 2019 | 1262 | 0.250 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2005 | 42 | 0.250 |
Why?
|
| Communication | 1 | 2010 | 558 | 0.240 |
Why?
|
| Aged | 10 | 2017 | 13595 | 0.240 |
Why?
|
| Resuscitation | 2 | 2018 | 71 | 0.240 |
Why?
|
| Positive-Pressure Respiration | 2 | 2018 | 48 | 0.230 |
Why?
|
| Algorithms | 1 | 2009 | 1006 | 0.220 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 202 | 0.220 |
Why?
|
| United States | 8 | 2018 | 7622 | 0.220 |
Why?
|
| Treatment Outcome | 6 | 2013 | 5266 | 0.220 |
Why?
|
| Fungemia | 1 | 2003 | 7 | 0.210 |
Why?
|
| Peptides, Cyclic | 1 | 2003 | 21 | 0.210 |
Why?
|
| Opportunistic Infections | 1 | 2003 | 27 | 0.210 |
Why?
|
| Pleural Effusion | 1 | 2003 | 34 | 0.210 |
Why?
|
| Middle Aged | 10 | 2019 | 16541 | 0.210 |
Why?
|
| Candidiasis | 1 | 2003 | 40 | 0.210 |
Why?
|
| Body Height | 2 | 2013 | 75 | 0.210 |
Why?
|
| Anti-Bacterial Agents | 2 | 2012 | 735 | 0.200 |
Why?
|
| Cohort Studies | 2 | 2019 | 2480 | 0.200 |
Why?
|
| Antifungal Agents | 1 | 2003 | 116 | 0.200 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 1036 | 0.200 |
Why?
|
| Ventilators, Mechanical | 1 | 2022 | 31 | 0.190 |
Why?
|
| Body Weight | 2 | 2013 | 381 | 0.190 |
Why?
|
| Neuromuscular Blockade | 2 | 2016 | 9 | 0.190 |
Why?
|
| APACHE | 2 | 2019 | 52 | 0.180 |
Why?
|
| Time Factors | 3 | 2012 | 3621 | 0.160 |
Why?
|
| Peptides | 1 | 2003 | 549 | 0.160 |
Why?
|
| New England | 1 | 2019 | 268 | 0.150 |
Why?
|
| Oxygen | 2 | 2013 | 309 | 0.150 |
Why?
|
| Retrospective Studies | 4 | 2019 | 6147 | 0.150 |
Why?
|
| Operating Rooms | 1 | 2018 | 54 | 0.150 |
Why?
|
| Linear Models | 1 | 2019 | 423 | 0.150 |
Why?
|
| Respiration | 1 | 2018 | 88 | 0.150 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 928 | 0.140 |
Why?
|
| Emergencies | 1 | 2018 | 114 | 0.140 |
Why?
|
| Prospective Studies | 5 | 2012 | 3132 | 0.140 |
Why?
|
| Incidence | 2 | 2018 | 1267 | 0.140 |
Why?
|
| Prognosis | 2 | 2019 | 1591 | 0.140 |
Why?
|
| Patient-Centered Care | 1 | 2019 | 250 | 0.130 |
Why?
|
| Intubation, Intratracheal | 1 | 2018 | 192 | 0.130 |
Why?
|
| Wavelet Analysis | 1 | 2015 | 5 | 0.130 |
Why?
|
| Automation | 1 | 2015 | 58 | 0.130 |
Why?
|
| Decision Making | 1 | 2019 | 394 | 0.130 |
Why?
|
| Pressure | 1 | 2015 | 75 | 0.130 |
Why?
|
| Heart | 1 | 2017 | 276 | 0.120 |
Why?
|
| Kidney | 1 | 2017 | 397 | 0.120 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2015 | 98 | 0.120 |
Why?
|
| Arteries | 1 | 2015 | 75 | 0.120 |
Why?
|
| Odds Ratio | 1 | 2017 | 774 | 0.120 |
Why?
|
| Prevalence | 1 | 2018 | 1299 | 0.110 |
Why?
|
| United States Food and Drug Administration | 2 | 2011 | 95 | 0.110 |
Why?
|
| Ultrasonography | 2 | 2015 | 460 | 0.110 |
Why?
|
| Hypovolemia | 1 | 2013 | 17 | 0.110 |
Why?
|
| Heart Injuries | 1 | 1993 | 18 | 0.110 |
Why?
|
| Palliative Care | 1 | 2016 | 215 | 0.110 |
Why?
|
| Carboxyhemoglobin | 1 | 2013 | 13 | 0.110 |
Why?
|
| Rhabdomyolysis | 1 | 2013 | 26 | 0.110 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2013 | 17 | 0.110 |
Why?
|
| Glasgow Coma Scale | 1 | 2013 | 44 | 0.110 |
Why?
|
| Emergency Medicine | 1 | 2015 | 185 | 0.110 |
Why?
|
| Liver | 1 | 2017 | 785 | 0.110 |
Why?
|
| Blood Volume Determination | 1 | 2012 | 4 | 0.100 |
Why?
|
| Hospitals | 1 | 2016 | 377 | 0.100 |
Why?
|
| Lung | 1 | 2017 | 842 | 0.100 |
Why?
|
| Goals | 1 | 2013 | 91 | 0.100 |
Why?
|
| Arterial Pressure | 1 | 2012 | 21 | 0.100 |
Why?
|
| Risk | 1 | 2013 | 376 | 0.100 |
Why?
|
| Precision Medicine | 1 | 2013 | 105 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2019 | 1936 | 0.100 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 332 | 0.100 |
Why?
|
| Oxazolidinones | 1 | 2012 | 14 | 0.100 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2012 | 12 | 0.100 |
Why?
|
| Acetamides | 1 | 2012 | 13 | 0.100 |
Why?
|
| Coronary Artery Bypass | 1 | 2013 | 276 | 0.090 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 66 | 0.090 |
Why?
|
| Industry | 1 | 2011 | 61 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2013 | 461 | 0.090 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 546 | 0.090 |
Why?
|
| Apnea | 1 | 2011 | 31 | 0.090 |
Why?
|
| Patient Positioning | 1 | 2011 | 43 | 0.090 |
Why?
|
| Ventricular Function, Left | 1 | 2012 | 264 | 0.090 |
Why?
|
| Pneumothorax | 1 | 2011 | 45 | 0.090 |
Why?
|
| Tissue Donors | 1 | 2011 | 134 | 0.090 |
Why?
|
| Electrocardiography | 1 | 1993 | 529 | 0.090 |
Why?
|
| Cross Infection | 1 | 2012 | 154 | 0.090 |
Why?
|
| Central Venous Pressure | 1 | 2009 | 13 | 0.080 |
Why?
|
| Tidal Volume | 1 | 2009 | 36 | 0.080 |
Why?
|
| Laparoscopy | 1 | 2013 | 401 | 0.080 |
Why?
|
| Professional-Family Relations | 1 | 2010 | 89 | 0.080 |
Why?
|
| Brain | 1 | 2017 | 1485 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1038 | 0.080 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2000 | 719 | 0.080 |
Why?
|
| Quality Improvement | 1 | 2013 | 428 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2011 | 298 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 197 | 0.070 |
Why?
|
| Young Adult | 1 | 2017 | 4398 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2007 | 1565 | 0.070 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2006 | 24 | 0.070 |
Why?
|
| Blood Pressure Determination | 1 | 2007 | 43 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 869 | 0.070 |
Why?
|
| Regional Blood Flow | 1 | 2006 | 108 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2005 | 694 | 0.070 |
Why?
|
| Radial Artery | 1 | 2007 | 49 | 0.060 |
Why?
|
| Oxygen Consumption | 1 | 2006 | 204 | 0.060 |
Why?
|
| Wounds, Penetrating | 1 | 2006 | 24 | 0.060 |
Why?
|
| Drug Costs | 1 | 2005 | 59 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2006 | 189 | 0.060 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2004 | 3 | 0.060 |
Why?
|
| Equipment Design | 2 | 1996 | 319 | 0.050 |
Why?
|
| Echinocandins | 1 | 2003 | 4 | 0.050 |
Why?
|
| Lipopeptides | 1 | 2003 | 17 | 0.050 |
Why?
|
| Fluconazole | 1 | 2003 | 14 | 0.050 |
Why?
|
| Amphotericin B | 1 | 2003 | 22 | 0.050 |
Why?
|
| Patient Selection | 1 | 2005 | 453 | 0.050 |
Why?
|
| Candida | 1 | 2003 | 34 | 0.050 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2003 | 48 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 685 | 0.050 |
Why?
|
| Neutropenia | 1 | 2003 | 66 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 170 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2006 | 699 | 0.040 |
Why?
|
| Neuromuscular Junction | 2 | 2016 | 83 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2007 | 5200 | 0.040 |
Why?
|
| Neuromuscular Monitoring | 1 | 2016 | 2 | 0.030 |
Why?
|
| Status Asthmaticus | 1 | 2016 | 7 | 0.030 |
Why?
|
| Myasthenia Gravis | 1 | 2016 | 8 | 0.030 |
Why?
|
| Withholding Treatment | 1 | 2016 | 40 | 0.030 |
Why?
|
| Hypothermia, Induced | 1 | 2016 | 41 | 0.030 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 74 | 0.030 |
Why?
|
| Poverty Areas | 1 | 2016 | 16 | 0.030 |
Why?
|
| Subclavian Vein | 1 | 1996 | 13 | 0.030 |
Why?
|
| Equipment Safety | 1 | 1996 | 21 | 0.030 |
Why?
|
| Analgesics | 1 | 2016 | 101 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2003 | 1481 | 0.030 |
Why?
|
| Demography | 1 | 2016 | 178 | 0.030 |
Why?
|
| Equipment Failure | 1 | 1993 | 64 | 0.030 |
Why?
|
| Cost Savings | 1 | 1993 | 56 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2004 | 1471 | 0.030 |
Why?
|
| Rehydration Solutions | 1 | 2012 | 4 | 0.030 |
Why?
|
| Heart Atria | 1 | 1993 | 138 | 0.030 |
Why?
|
| Isotonic Solutions | 1 | 2012 | 15 | 0.030 |
Why?
|
| Cause of Death | 1 | 1993 | 205 | 0.030 |
Why?
|
| Colloids | 1 | 2012 | 50 | 0.020 |
Why?
|
| Linezolid | 1 | 2012 | 7 | 0.020 |
Why?
|
| Radiography | 1 | 1993 | 514 | 0.020 |
Why?
|
| Catheterization, Peripheral | 1 | 1990 | 46 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 2361 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 1993 | 713 | 0.020 |
Why?
|
| Obesity | 1 | 2016 | 1191 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 2003 | 59 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2004 | 684 | 0.010 |
Why?
|
| Forecasting | 1 | 2003 | 220 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2000 | 73 | 0.010 |
Why?
|
| Insurance, Health | 1 | 2000 | 143 | 0.010 |
Why?
|
| Risk Factors | 1 | 2003 | 5090 | 0.010 |
Why?
|
| Palpation | 1 | 1990 | 10 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 1990 | 59 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1990 | 639 | 0.000 |
Why?
|